Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooke R Bartley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cureus|July 11, 2025
Expanding the Clinical Spectrum of Porokeratosis PtychotropicaBrooke R Bartley, Dylan R Maldonado, Steven Mays, et al.
International Journal of Dermatology|December 28, 2022
Current treatments and emerging therapies of human polyomavirus-associated skin diseases: a comprehensive reviewBrooke R Bartley, Stephen A Moore, Hung Q Doan, et al.
Virus Genes|January 9, 2022
Trichodysplasia spinulosa polyomavirus small T antigen synergistically modulates S6 protein translation and DNA damage response pathways to shape host cell environmentDeepika Narayanan, Danyal Tahseen, Brooke R Bartley, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2022
The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive reviewJennifer R Landes, Stephen A Moore, Brooke R Bartley, et al.
Clinical and Experimental Dermatology|May 16, 2023
Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell linesJennifer R Landes, Brooke R Bartley, Stephen A Moore, et al.
JAMA Dermatology|April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus StatementJoseph F Merola, Beth A Childs, Brooke R Bartley, et al.
Journal of Cutaneous Pathology|March 9, 2022
Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49Brooke R Bartley, Auris Huen, Peter L Rady, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cureus|July 11, 2025
Expanding the Clinical Spectrum of Porokeratosis PtychotropicaBrooke R Bartley, Dylan R Maldonado, Steven Mays, et al.
International Journal of Dermatology|December 28, 2022
Current treatments and emerging therapies of human polyomavirus-associated skin diseases: a comprehensive reviewBrooke R Bartley, Stephen A Moore, Hung Q Doan, et al.
Virus Genes|January 9, 2022
Trichodysplasia spinulosa polyomavirus small T antigen synergistically modulates S6 protein translation and DNA damage response pathways to shape host cell environmentDeepika Narayanan, Danyal Tahseen, Brooke R Bartley, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2022
The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive reviewJennifer R Landes, Stephen A Moore, Brooke R Bartley, et al.
Clinical and Experimental Dermatology|May 16, 2023
Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell linesJennifer R Landes, Brooke R Bartley, Stephen A Moore, et al.
JAMA Dermatology|April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus StatementJoseph F Merola, Beth A Childs, Brooke R Bartley, et al.
Journal of Cutaneous Pathology|March 9, 2022
Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49Brooke R Bartley, Auris Huen, Peter L Rady, et al.
Pageof 1